Succeeding in the US Flow Cytometry Market, 2019-2023: Analyzers and Reagents--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

This report presents a comprehensive analysis of the US flow cytometry market, including:

  • Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories.
  • Annual placements and installed base of major flow cytometers.
  • Review of current instrumentation technologies and a feature comparison of leading systems.
  • Five-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging diagnostic technologies, and their potential market applications.
  • Product development opportunities for new instruments, consumables, and auxiliary products.
  • Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
  • Business opportunities and strategic recommendations for suppliers.


I. Introduction
II. Worldwide Market and Technology Overview
A. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
Instrumentation and
Reagent Test Kits
* BD FACS Count
* Beckman Coulter VCS
* T Cells Diagnostics TRAx
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Reticulocytes
7. Chromosome Analysis
8. Fetal Cell Analysis
9. HLA Typing
10. Microbiology
11. Protein Content Analysis
12. Multiparameter Analysis
13. Other Applications
B. Instrumentation Review
a. Introduction
b. System Overview
BD FACSadvantage
BD FACSAria III
BD FACSCalibur
BD FACScan
BD FACSCanto II
BD FACSCount
BD FACSort
BD FACStar Series
BD FACStrak


BD FACS Vantage
BD Influx
Beckman Coulter Epics C
Beckman Coulter Epics Elite Analyzer
Beckman Coulter Epics Elite ESP
Beckman Coulter Epics Profile
Beckman Coulter Epics XL
Beckman Coulter FC 500 Series
Beckman Coulter Vi-CELL XR
C. Current Market Needs and Future Demand for
Hematology Analyzers
D. Reagents and Controls
E. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. U.S.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases

12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers
Instrument Placements, Installed Base, Sales
and Market Share
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
Horiba
Iris Diagnostics/Danaher
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex

IX. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications

List Of Tables




U.S., Laboratories Performing
Hematology/Flow Cytometry Tests
By Market Segment
U.S., Hospital Laboratories Performing
Hematology/Flow Cytometry Tests By Bed Size
U.S., Commercial/Private Laboratories
Performing Hematology/Flow Cytometry Tests
By Annual Test Volume
U.S., Physician Offices/Group Practices
Performing Hematology/Flow Cytometry Tests
By Practice Size
U.S., Total Flow Cytometry and Special
Hematology Specimen Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special
Hematology Specimen Volume Forecast
U.S., All Market Segments Flow Cytometry and
Special Hematology Test Volume Forecast

U.S., Hospital Laboratories, Flow Cytometry and
Special Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Flow Cytometry
And Special Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Flow Cytometry
And Special Hematology Test Volume Forecast
U.S., Major Flow Cytometers, Estimated
Placements and Installed Base
U.S., Total Flow Cytometry Diagnostics Market
Forecast By Market Segment

U.S., Flow Cytometry Instrument Market Forecast
By Market Segment
U.S., Flow Cytometry Consumable Market Forecast
By Market Segment
U.S., Total Flow Cytometry Diagnostics Market
By Major Supplier
U.S., Total Flow Cytometry Instrument Market
By Major Supplier
U.S., Total Flow Cytometry Consumables Market
By Major Supplier


Succeeding in the Yersinia Diagnostics Market, 2019-2023: USA, Europe, Japan--Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--Hospitals, Commercial and Public Health Labs, POC Locations

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  The report provides volume and sales forecasts for Yersinia tests performed

USD 600 View Report

Succeeding in the Vibrio Diagnostics Market, 2019-2023: USA, Europe, Japan--Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--Hospitals, Commercial and Public Health Labs, POC Locations

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Vibrio tests performed

USD 550 View Report

COVID-19 Outbreak-Global Generator in the Data Center Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

The Tier Classification System refers to a benchmarking system from Uptime Institute to determine the availability, or uptime, of a data center. A number of factors determine what tier a

USD 3660 View Report

COVID-19 Outbreak-Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Biomarkers are an objective measure of measurement and assessment as indicators of normal biological processes, pathogenic processes or pharmacological responses to therapeutic interventions. Biomarkers take the form of cell characteristics,

USD 3660 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available